Home Overview Press Room Blog Publications For Students about us
Search

About Egg Retrieval


Scientists working to perform research cloning require large numbers of women's eggs for their efforts. Egg retrieval is invasive, time-consuming, uncomfortable, and—most important—puts women at risk of significant adverse reactions.

In order to procure eggs, researchers give women hormonal drugs to first "shut down" and then "hyperstimulate" their ovaries to produce more eggs than normal. These eggs are then surgically extracted.

Egg retrieval for assisted reproduction has been conducted for several decades, but there is inadequate data on its risks. Follow-up studies on long-term risks are particularly lacking; those that do exist are inconclusive.

Short-term reactions to one commonly used "shut-down" drug include severe joint pain, difficulty breathing, chest pain, depression, amnesia, hypertension, and asthma. The drugs used to stimulate multiple egg production can cause ovarian hyperstimulation syndrome (OHSS), which is often a mild reaction but which can become serious enough to require hospitalization and, rarely, to cause death.

Some women's health advocates and others have questioned whether researchers should ask women to expose themselves to these risks, especially in light of the early and speculative stage of cloning research. Proposals to pay women to provide eggs for research remain controversial, as this practice could tempt economically vulnerable women to take risks they otherwise would avoid.



Inside New York’s Radical Egg-Freezing Clinic for Women[citing CGS' Marcy Darnovsky]by Lizzie Crocker & Abby HaglageThe Daily BeastAugust 10th, 2016Extend Fertility in Manhattan offers egg freezing at half market price. It’s also the first standalone practice of its kind in the U.S.
Booming demand, state protections attract commercial surrogate birthingby Kathy RobertsonSacramento BeeAugust 5th, 2016California has more surrogacy regulation than most states. But the founder of an agency comments, "Anybody in the whole world – even a felon – can open an agency. There is no licensing, no background check."
The Human Egg Business: More Media Coverage of California Cash-for-Eggs Legislation[citing CGS]by David JensenCalifornia Stem Cell ReportAugust 5th, 2016AB2531 is backed by the fertility industry and would remove caps on payments for egg retrieval to induce women to gamble with their health.
Bill to expand market in women’s egg donations would undermine safeguards[citing CGS]by Deborah OrtizSacramento BeeAugust 4th, 2016Let’s not repeal a law that safeguards the health of women. We can support biomedical research without putting women’s health at risk.
It's time for a conversation on parental surrogacy rulesby Celine CooperMontreal GazetteJuly 31st, 2016Is Montreal inching closer to relaxing or even abandoning its entrenched disapproval of procreative surrogacy?
35 couples used surrogates since new law in placeThe Nation [Thailand]July 31st, 2016Government agencies will track outcomes for women working as surrogates and children born in surrogacy arrangements, and analyse information on ways to improve regulations.
Turning back the biological clock comes at a price by Rhiannon Lucy CosslettThe GuardianJuly 25th, 2016Egg freezing is marketed as the answer to precarious young lives yet excludes most of those it claims to help.
What No One Tells You About Egg Donorsby Leah CampbellMom.meJuly 22nd, 2016The profit-driven egg industry does not take the medical needs of egg donors or their right to informed choice seriously.
Should we pay women to donate their eggs for research? No, and here's why.[citing CGS’ Marcy Darnovsky, fellow Lisa Ikemoto]by Michael HiltzikThe Los Angeles TimesJuly 22nd, 2016The risks of egg retrieval, particularly long-term risks, are not yet understood due to a lack of studies.
Who should we believe when it comes to fertility?New ScientistJuly 20th, 2016Difficult choices over when to start a family are not made any easier by conflicting signals from doctors and fertility clinics.
Displaying 1-10 of 830  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760